These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25169073)

  • 41. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
    Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
    Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
    Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
    Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
    Olliaro PL; Delenne H; Cisse M; Badiane M; Olliaro A; Vaillant M; Brasseur P
    Malar J; 2008 Nov; 7():234. PubMed ID: 18992140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
    Agyeman YN; Newton S; Annor RB; Owusu-Dabo E
    PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
    Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
    Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey.
    Hill J; Kayentao K; Touré M; Diarwara S; Bruce J; Smedley J; Doumbo OK; ter Kuile FO; Webster J
    PLoS One; 2014; 9(3):e92102. PubMed ID: 24651078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kombila M
    BMC Pregnancy Childbirth; 2013 Feb; 13():52. PubMed ID: 23442536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimalarials during pregnancy: a cost-effectiveness analysis.
    Schultz LJ; Steketee RW; Chitsulo L; Wirima JJ
    Bull World Health Organ; 1995; 73(2):207-14. PubMed ID: 7743592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
    Toure OA; Kone PL; Coulibaly MA; Ako BA; Gbessi EA; Coulibaly B; N' Guessan LT; Koffi D; Beourou S; Soumahoro A; Bassinka I; Nogbou M; Swa T; Gba B; Esmel B; Bokossa EM
    Parasit Vectors; 2014 Nov; 7():495. PubMed ID: 25410760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
    J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reaching the unreached: effectiveness and satisfaction with community-directed distribution of sulfadoxine-pyrimethamine for preventing malaria in pregnancy in rural South-East, Nigeria.
    Okedo-Alex IN; Akamike IC; Alo CN; Agu AP; Nzeh CB; Ndukwe CD; Okoro OO; Abateneh DD; Uneke CJ
    Malar J; 2020 Nov; 19(1):394. PubMed ID: 33160375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Hill J; Ouma P; Oluoch S; Bruce J; Kariuki S; Desai M; Webster J
    Malar J; 2020 Nov; 19(1):433. PubMed ID: 33238999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.
    Tinto H; Sevene E; Dellicour S; Calip GS; d'Alessandro U; Macete E; Nakanabo-Diallo S; Kazienga A; Valea I; Sorgho H; Valá A; Augusto O; Ruperez M; Menendez C; Ouma P; Desai M; Ter Kuile F; Stergachis A
    Reprod Health; 2015 Dec; 12():112. PubMed ID: 26637464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
    Sangaré LR; Stergachis A; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Weiss NS
    PLoS One; 2010 Nov; 5(11):e15066. PubMed ID: 21124732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    ACCESS-SMC Partnership
    Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda.
    Mbonye AK; Hansen KS; Bygbjerg IC; Magnussen P
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):685-93. PubMed ID: 18513767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.